1. Home
  2. News
  3. Zhejiang Shengda Bio-Pharm Co., Ltd.
  4. (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Report for Q3 2026
More Zhejiang Shengda Bio-Pharm Co., Ltd. news
Zhejiang Shengda Bio-Pharm Co., Ltd.SSE: 603079

(603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Report for Q3 2026

Oct 28, 2026 · Issued by Zhejiang Shengda Bio-Pharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603079 · Oct 28, 2026 · 11 pages · Chinese

On 6ix: 6ix.com/news/603079zhejiang-shengda-bio-pharm-co-ltdreport-for-q3-2026

Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix

Earlier from Zhejiang Shengda Bio-Pharm

  • (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Repurchasing SharesOct 16
  • (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash ManagementOct 14
  • (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised FundsOct 9
  • Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash ManagementOct 1
All Zhejiang Shengda Bio-Pharm news releases↗

Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.

Follow Zhejiang Shengda Bio-Pharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer